Net Cash Provided by (Used in) Operating Activities |
-212K |
USD |
-199% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
1M |
USD |
|
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-286K |
USD |
-240% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
25.2M |
shares |
+74.1% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
501K |
USD |
|
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
2.15M |
USD |
+26% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
2.15M |
USD |
+26% |
Q4 2023 |
FY 2023 |
Payments to Acquire Property, Plant, and Equipment |
525K |
USD |
|
Q2 2023 |
Q3 2023 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-4.17M |
USD |
-534% |
Q2 2022 |
Q2 2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.79M |
USD |
+7.53% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
30.7M |
USD |
+167% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
1.71M |
USD |
-31.4% |
Q4 2022 |
FY 2022 |
Share-based Payment Arrangement, Expense |
3.21M |
USD |
+471% |
Q2 2022 |
Q2 2022 |
Interest Expense |
203K |
USD |
|
Q1 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |